Research progress of ERCC1 in non-small cell lung cancer based on the platinum drugs / 国际肿瘤学杂志
Journal of International Oncology
;
(12): 909-912, 2014.
Article
in Chinese
| WPRIM
| ID: wpr-458827
ABSTRACT
Excision repair cross complementing group 1 (ERCC1) gene is an enzyme of the speed limit of DNA repair protein in nucleotide excision repair (NER) pathways.Researches suggest that ERCC1 has been associated with cisplatin resistance in non-small cell lung cancer (NSCLC) patients.Thus,ERCC1 gene is a new target in malignant tumor gene therapy research,providing a new approach for the treatment of malignant,especially NSCLC.
Full text:
Available
Index:
WPRIM (Western Pacific)
Language:
Chinese
Journal:
Journal of International Oncology
Year:
2014
Type:
Article
Similar
MEDLINE
...
LILACS
LIS